H3-4: A Protein Targeted for Cancer and Neurodegenerative Diseases
H3-4: A Protein Targeted for Cancer and Neurodegenerative Diseases
H3-4, also known as H3/g, is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
One of the defining features of H3-4 is its unique structure. It consists of three domains: an N-terminus, a transmembrane region, and a C-terminus. The N-terminus contains a unique farnesylated cysteine residue, which is important for its stability and functions as a receptor. The transmembrane region is rich in electrolytes and contains several unique ion channels that play important roles in maintaining the stability of the membrane. The C-terminus contains several conserved tyrosine residues that are involved in the regulation of cellular processes such as cell adhesion and migration.
H3-4 has been shown to play a number of important roles in various physiological processes, including cell growth and differentiation, angiogenesis, and inflammation. It has been shown to promote the growth and survival of cancer cells, and to contribute to the development of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. It is also involved in the regulation of inflammation, and has been shown to play a key role in the development of autoimmune disorders.
Due to its unique structure and its involvement in various important biological processes, H3-4 has been identified as a potential drug target. Several studies have shown that inhibiting H3-4 can lead to a variety of therapeutic effects, including the inhibition of cancer cell growth, the regression of neurodegenerative diseases, and the improvement of autoimmune disorders.
One of the challenges in targeting H3-4 is its widespread distribution in the body. While it is expressed in many different tissues, it is not a well-targeted protein, and its effects are not limited to a specific cell type or tissue. This makes it difficult to predict the outcome of a drug treatment, and to develop specific and effective therapies.
Another challenge is the complexity of the H3-4 signaling pathway. It is not clear how all of the different components of the pathway work together to regulate cellular processes, and it is difficult to identify the precise target of a given signaling pathway. This makes it difficult to develop specific and effective therapies, and to understand the underlying mechanisms of the disease.
Despite these challenges, research into H3-4 is ongoing, and several potential drug targets are being explored. One of the most promising targets is the farnesylated cysteine residue in the N-terminus, which is involved in the regulation of cellular processes and has been shown to play a key role in the development of neurodegenerative diseases. Another potential target is the transmembrane region, which is rich in unique ion channels and has been shown to play important roles in the regulation of cellular processes.
In conclusion, H3-4 is a protein that has important roles in various physiological processes, including cell growth and differentiation, angiogenesis, and inflammation. Its unique structure and its involvement in a number of diseases make it a potential drug target, and research is ongoing to identify the precise target of the H3-4 signaling pathway and to develop effective therapies.
Protein Name: H3.4 Histone, Cluster Member
Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling
The "H3-4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H3-4 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3 | HAUS4 | HAUS5 | HAUS6 | HAUS7 | HAUS8 | HAVCR1 | HAVCR1P1 | HAVCR2 | HAX1 | HAX1P1 | HBA1 | HBA2 | HBAP1 | HBB | HBBP1 | HBD
